ZEVASKYN 40 cm2/1
prademagene zamikeracel · CELLULAR SHEET · Abeona Therapeutics Inc.
ZEVASKYN is a cellular sheet containing prademagene zamikeracel at 40 cm2/1, taken topical. Manufactured by Abeona Therapeutics Inc..
Key Facts
- Brand Name
- ZEVASKYN
- Generic Name
- prademagene zamikeracel
- NDC Code (Product)
84103-007- Manufacturer
- Abeona Therapeutics Inc.
- Strength
- 40 cm2/1
- Dosage Form
- CELLULAR SHEET
- Route
- TOPICAL
- Marketing Status
- Application #
- BLA125807
- Marketing Start
- 06/15/2025
Recall History
No Recall HistoryFrequently Asked Questions
What is ZEVASKYN used for?
ZEVASKYN contains prademagene zamikeracel. It is a cellular sheet taken topical. Consult your doctor for specific uses.
Is ZEVASKYN a controlled substance?
ZEVASKYN is not classified as a controlled substance by the DEA.
What is the generic name for ZEVASKYN?
The generic name for ZEVASKYN is prademagene zamikeracel. There are no other listed brand versions of prademagene zamikeracel.
What is the NDC code for ZEVASKYN 40 cm2/1?
The NDC (National Drug Code) for ZEVASKYN 40 cm2/1 is 84103-007, listed by Abeona Therapeutics Inc..
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)